肾癌的外科治疗  

Operative treatment of renal carcinoma

作　　者：谢炳柱[1] 臧奕[1] 詹敏[1] 陈凌武[2] 梁辉[2] 

机构地区：[1]广东医学院第三附属医院泌尿外科,广东茂名525011 [2]中山医科大学第一附属医院泌尿外科,广东广州510100

出　　处：《海南医学院学报》2007年第2期142-143,146,共3页Journal of Hainan Medical University

摘　　要：目的:提高肾癌的诊治水平。方法:对92例肾细胞癌患者的诊治和预后情况进行回顾性分析。肾癌根治性切除术80例、姑息性肾切除5例、保留肾单位手术7例。结果:92例术后病理诊断,透明细胞癌65例(70.6%),乳头状细胞癌21例(22.8%),嫌色细胞癌5例(5.4%),集合管癌1例(1.1%)。随访75例,5年生存率1期89.7%(35/39),2期80%(16/20),3期53.8%(7/13),4期33.3%(1/3)。结论:外科手术仍然是肾癌最重要的预后因素。Objective. To improve the level for diagnosis and treatment of renal cell carcinoma. Methods： 92 cases of patients with renal cell carcinoma were retrospectively analyzed for their diagnosis, treatment and prognosis. Radical nephrectomy was carried out on 80 cases. Simple nephrectomy was carried out on 5 cases and nephron sparing surgery （NSS） on 7cases. Results： The pathological studies showed that 65 cases （70. 6%） were clear cell carcinoma, 21 cases （22.8%） of papillary cell carcinoma, 5 cases （5.4%） of chromophobe cell carcinoma, 1 case （1.1%） of collecting duct cell carcinoma. 75 cases conducted successfully followed and the 5 year survival rate for stage Ⅰ, Ⅱ,Ⅲ and Ⅳ tumors were 89.7%, 80. 0%, 53.8 %and 33.3% respectively. Conclusion. The most important prognostic factor for renal cell carcinoma is surgery operation.

关 键 词：肾 癌 外科手术 

分 类 号：R737.11[医药卫生—肿瘤]